CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 63 filers reported holding CUE BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $310,500 | -36.5% | 135,000 | +0.7% | 0.02% | -42.9% |
| Q2 2023 | $489,231 | -46.1% | 134,036 | -47.2% | 0.04% | -50.6% |
| Q1 2023 | $906,909 | -12.8% | 254,036 | -30.4% | 0.08% | +7.6% |
| Q4 2022 | $1,040,250 | -12.8% | 365,000 | -31.8% | 0.08% | -12.2% |
| Q3 2022 | $1,193,000 | -17.4% | 535,000 | -7.8% | 0.09% | -9.1% |
| Q2 2022 | $1,444,000 | -26.9% | 580,000 | +43.2% | 0.10% | -26.7% |
| Q1 2022 | $1,976,000 | -8.1% | 405,000 | +113.2% | 0.14% | +8.9% |
| Q4 2021 | $2,149,000 | +43.5% | 190,000 | +84.8% | 0.12% | +57.0% |
| Q3 2021 | $1,498,000 | -14.7% | 102,816 | -31.8% | 0.08% | -7.1% |
| Q2 2021 | $1,756,000 | -6.9% | 150,700 | -2.5% | 0.08% | +21.4% |
| Q1 2021 | $1,886,000 | +77.4% | 154,600 | +81.9% | 0.07% | +84.2% |
| Q4 2020 | $1,063,000 | – | 85,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,915,219 | $23,959,000 | 5.70% |
| Prosight Management, LP | 906,569 | $11,341,000 | 5.24% |
| P.A.W. CAPITAL CORP | 140,000 | $1,751,000 | 1.54% |
| Voss Capital, LLC | 220,714 | $2,761,000 | 1.39% |
| Robertson Stephens Wealth Management, LLC | 484,000 | $6,054,000 | 1.26% |
| Slate Path Capital LP | 1,483,619 | $18,560,000 | 1.00% |
| Nantahala Capital Management | 2,506,772 | $31,360,000 | 0.97% |
| PRECEPT MANAGEMENT LLC | 150,000 | $1,877,000 | 0.76% |
| SANDERS MORRIS HARRIS LLC | 193,591 | $2,449,000 | 0.56% |
| Rock Creek Group, LP | 100,014 | $1,251,000 | 0.51% |